Proveris Scientific Corp. v. Innovasystems, Inc.

739 F.3d 1367, 109 U.S.P.Q. 2d (BNA) 1314, 2014 WL 104025, 2014 U.S. App. LEXIS 585
CourtCourt of Appeals for the Federal Circuit
DecidedJanuary 13, 2014
Docket18-2273
StatusPublished
Cited by35 cases

This text of 739 F.3d 1367 (Proveris Scientific Corp. v. Innovasystems, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Proveris Scientific Corp. v. Innovasystems, Inc., 739 F.3d 1367, 109 U.S.P.Q. 2d (BNA) 1314, 2014 WL 104025, 2014 U.S. App. LEXIS 585 (Fed. Cir. 2014).

Opinion

PROST, Circuit Judge.

Innovasystems, Inc. (“Innova”) appeals from two final judgments of the U.S. District Court for the District of Massachusetts holding Innova in contempt of that court’s May 11, 2007 injunction and awarding sanctions in the amount of $878,205. Proveris Scientific Corp. (“Proveris”) cross-appeals the district court’s denial of sanctions for certain of Innova’s sales. Because we conclude that the district court erred in failing to construe the disputed claim language, we vacate the contempt order and remand for claim construction and renewed contempt proceedings.

Background

Proveris is the owner of U.S. Patent No. 6,785,400 (“'400 patent”). The '400 patent relates to a mechanism for evaluating aerosol spray plumes. The apparatus claimed therein is used to observe the delivery of drugs that are administered through spray devices, such as inhalers or nasal sprays. The invention involves triggering a spray plume and collecting data on the plume via an illumination device and an imaging device.

Innova previously made and sold a device known as the Optical Spray Analyzer (“OSA”). In 2005, Proveris filed a patent infringement lawsuit against Innova, alleging that the OSA product infringed the '400 patent. Innova conceded infringement of claims 3-10 and 13, but disputed infringement of claims 1-2. The district court excluded the testimony of Innova’s experts and consequently ruled in favor of Proveris on invalidity. After a jury trial *1370 on the remaining issues, the jury found that Innova did not infringe claims 1 or 2, and that no damages had been proven. However, based on the conceded infringement of claims 3-10 and 13, the district court granted Proveris a permanent injunction prohibiting Innova from “making, using, selling, offering for sale or importing into or exporting out of the United States” the OSA product. We affirmed. Provens Scientific Corp. v. Innovasystems, Inc., 536 F.3d 1256 (Fed.Cir.2008).

After that time, Innova modified its OSA product and began selling a new product known as the Aerosol Drug Spray Analyzer (“ADSA”) that it argues does not infringe independent claim 3 of the '400 patent. Innova claims that the OSA product allowed a user to identify what range of images he or she wanted to analyze before activating the spray plume, while the ADSA device requires the user to first activate the spray plume and then later determine what range of images he or she would like to analyze. It contends that this is a significant modification that renders the ADSA device non-infringing because the preamble of claim 3 specifies that the image data may be captured “at a predetermined instant in time.”

Proveris disagreed with Innova’s interpretation of that claim language and in March 2010 filed a contempt motion based on Innova’s manufacture and sale of the ADSA product. The district court initially scheduled a Marlcman hearing to construe the disputed claim term, but ultimately ruled that, because Innova could have raised claim construction issues in the underlying infringement action, the court would not construe claim 3 or import a limitation from the preamble of claim 3. The district court also said that, because Innova had already attempted to challenge the validity of claim 3 during the underlying infringement action, it could not now raise new invalidity arguments during the contempt proceedings. On the merits, the district court entered a contempt order against Innova, thereby implicitly finding that the ADSA product was not more than colorably different from the infringing OSA product and that it, too, infringed the '400 patent.

A bench trial was then held on the issue of sanctions. The court found that Inno-va’s violation of the injunction had been willful and ordered disgorgement of any profits Innova had acquired from sales of the ADSA product. Proveris also sought to recover profits from Innova’s sale of various component parts to overseas locations, but the district court ruled that those actions did not fall within the scope of the injunction, so Proveris would have to establish liability in a separate action before damages could be awarded for, those sales.

Innova has appealed both the contempt order and the ensuing sanctions. Proveris has cross-appealed certain aspects of the district court’s sanctions ruling.

Discussion

In evaluating whether an injunction against continued infringement has been violated by a newly accused product, courts must follow the two-step test outlined in TiVo Inc. v. EchoStar Corp., 646 F.3d 869 (Fed.Cir.2011) (en banc). First, a party seeking to enforce an injunction must show that “the newly accused product is not more than colorably different from the product found to infringe.” Id. at 882. The analysis should focus on “those aspects of the accused product that were previously alleged to be, and were a basis for, the prior finding of infringement, and the modified features of the newly accused product.” Id. Where one or more of the elements previously found to infringe has been modified or removed, the court must determine whether that modifi *1371 cation is significant. Id. If so, the newly-accused product is more than colorably different from the infringing product, and contempt is not the appropriate remedy. Id. Instead, a new infringement action must be brought regarding the newly accused product. If, however, the court concludes that the differences are not more than colorable, the court must then go on to the second step and determine whether the newly accused product in fact infringes the relevant claims. Id. at 883.

Because the district court decided contempt based on the parties’ cross-motions for summary judgment, we review the contempt ruling de novo. See MeadWestVaco Corp. v. Rexam Beauty & Closures, Inc., 731 F.3d 1258, 1264 (Fed.Cir.2013). Summary judgment is appropriate when, drawing all justifiable inferences in the nonmov-ant’s favor, there exists no genuine issue of material fact and the movant is entitled to judgment as a matter of law. Fed. R.Civ.P. 56(c); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). Sanctions awards are reviewed for an abuse of discretion. TiVo, 646 F.3d at 883.

A. Colorable Differences

Innova argues that the OSA product was admitted to infringe claim 3 in part because that device had the ability to specify which images should be captured “at a predetermined time,” meaning before the spray plume was activated. And, as explained above, Innova claims to have removed that feature from the ADSA product. Thus, following the TiVo

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
739 F.3d 1367, 109 U.S.P.Q. 2d (BNA) 1314, 2014 WL 104025, 2014 U.S. App. LEXIS 585, Counsel Stack Legal Research, https://law.counselstack.com/opinion/proveris-scientific-corp-v-innovasystems-inc-cafc-2014.